Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners.

 

Commercial products

Development pipeline

Explore our business

Commercial Products

On the US market, Orexo’s own sales force commercializes innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases.

Products under Development

Orexo develops improved drugs based on well-known substances combined with innovative proprietary drug delivery technologies, such as amorphOX®.

Partnerships

Products targeting other therapeutic areas than opioid use disorder and adjacent diseases are developed and commercialized worldwide with leading partners.